Novavax Secures $1.6 Billion from U.S. Government for COVID-19 Vaccine Program
With rising numbers of COVID-19 infections and as the fight against the novel coronavirus continues, Novavax received $1.6 billion in federal funding to support the clinical development of the company’s vaccine candidate, NVX‑CoV2373. Gaithersburg ...